Eileen Yaralian is the Managing Partner and Chief Growth & Innovation Officer at REMEDY EDGE™, bringing over 20 years of experience in pharmaceutical, biotech, and medical device marketing strategy. She is a recognized expert in rare disease and oncology, with a degree from the University of Pennsylvania.
She is the Dean of Omnicom Health Groups Rare University and the Rare Collective.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.